OPTN/SRTR 2016 Annual Data Report: Pancreas

• Published in: American journal of transplantation Vol. 18; no. S1; pp. 114 - 171
• Main Authors: Kandaswamy, R., Stock, P. G., Gustafson, S. K., Skeans, M. A., Curry, M. A., Prentice, M. A., Fox, A., Israni, A. K., Snyder, J. J., Kasiske, B. L.
• Format: Journal Article
• Language: English
• Published: United States Wiley Subscription Services, Inc 01.01.2018
• Subjects: ABO system; Annual Reports as Topic; Graft rejection; Graft Survival; Grafts; Humans; Pancreas; pancreas after kidney transplant; Pancreas transplant; pancreas transplant alone; Pancreas Transplantation; Registries; simultaneous kidney pancreas transplant; Tissue and Organ Procurement; Tissue Donors; Transplantation; Transplants & implants; United States; Waiting Lists; United States; pancreas after kidney transplant; Pancreas transplant; simultaneous kidney pancreas transplant; pancreas transplant alone
• ISSN: 1600-6135; 1600-6143
• DOI: 10.1111/ajt.14558

The number of pancreas transplants performed in the United States increased by 7.0% in 2016 over the previous year, the first such increase in more than a decade, largely attributable to an increase in simultaneous kidney pancreas transplants. Transplant rates increased in 2016, and mortality on the waiting list decreased. The declining enthusiasm for pancreas after kidney (PAK) transplants persisted. The uniform definition of graft failure was approved by the OPTN Board of Directors in 2015 and will be implemented in early 2018. Meanwhile, SRTR continues to refrain from reporting pancreas graft failure data. The OPTN/UNOS Pancreas Transplantation Committee is seeking to broaden allocation of pancreata across compatible ABO blood types in a proposal out for public comment July 31 to October 2, 2017. A new initiative to provide guidance on the benefits of PAK transplants is also out for public comment.